CN209951568U

CN209951568U - Anti-bleeding injection patch after low-molecular heparin injection

Info

Publication number: CN209951568U
Application number: CN201920642023.0U
Authority: CN
Inventors: 董程洁; 刘君; 姜娇娇
Original assignee: Affiliated Hospital of Jiangsu University
Current assignee: Affiliated Hospital of Jiangsu University
Priority date: 2019-05-07
Filing date: 2019-05-07
Publication date: 2020-01-17
Anticipated expiration: 2029-05-07

Abstract

The utility model discloses a prevent injection subsides of bleeding after low molecular heparin injection, including the viscose layer, the middle part on viscose layer is provided with square groove, the one end on viscose layer bonds and has the layer that absorbs water, the one end middle part on the layer that absorbs water is provided with the medicine layer, the one end on the layer that absorbs water bonds and has the protective layer, the one end on medicine layer bonds and has the isolation layer. The utility model discloses a device is through pasting this device at the injection position, write the strip and write injection time just, whether the patient forgets that there is the evidence to follow when injecting, fail in time to discover to arouse patient panic after preventing to inject the position hemorrhage, through setting up the oxidation degree of warning strip according to magnesium and referring to injection time last time for the doctor, avoid writing on the strip just because patient friction fuzzily leads to unable understanding injection time, through setting up square groove, it absorbs to be convenient for inject the position hemorrhage and see through the layer that absorbs water, the medicine layer medicine of also being convenient for volatilizees injection department, through setting up the isolation layer, it outwards volatilizees to reduce the medicine.

Description

Anti-bleeding injection patch after low-molecular heparin injection

Technical Field

The utility model relates to the technical field of injection pastes, in particular to a bleeding-proof injection paste after low molecular heparin injection.

Background

Low molecular heparin (LMWH) is a novel anticoagulant drug which is decomposed and strengthened on the basis of common heparin, has extremely strong antithrombotic capacity, has the strength which is 2.2-3.5 times that of the common heparin, simultaneously has the advantages of long half-life period, high utilization rate, few adverse reactions and the like, and is widely applied in clinic. However, in the actual injection of the LMWH, the capillary vessels in the tissues of the patient are easily damaged, so that the patient has adverse reactions such as subcutaneous hemorrhage, ecchymosis and the like, physiological pain is caused to the patient, psychological panic, tension and other emotions of the patient are caused, even a part of patients often forget whether to inject, the situation of questioning medical work is generated, and further doctor-patient disputes are generated, and the treatment effect is influenced.

SUMMERY OF THE UTILITY MODEL

The main object of the utility model is to provide a prevent injection subsides of bleeding after low molecular heparin injection, can effectively solve the problem in the background art.

In order to achieve the above purpose, the utility model adopts the following technical scheme:

the utility model provides a prevent injection subsides of bleeding after low molecule heparin injection, includes the viscose layer, the middle part on viscose layer is provided with square groove, the one end on viscose layer bonds and has the layer that absorbs water, the one end middle part on the layer that absorbs water is provided with the medicine layer, the one end on the layer that absorbs water bonds and has the protective layer, the one end on medicine layer bonds and has the isolation layer, the one end of protective layer is provided with just writing the strip, just write one side of strip and be provided with warning strip.

Further, the viscose layer is of a medical silicone gel material, the size of a square groove formed in the middle of the viscose layer is consistent with that of the medicine layer, and the lower side surface of the viscose layer is coated with a pressure-sensitive adhesive.

Furthermore, the water absorbing layer is made of fiber cotton and adopts a multilayer combined structure.

Further, the isolating layer is a polyurethane plastic film, and the size of the isolating layer is consistent with that of the medicine layer.

Furthermore, the protective layer is a fabric woven by absorbent cotton materials, and one side of the protective layer is thinner than the other side of the protective layer.

Furthermore, the note of just writing is bonded in the thinner one side of protective layer through glue, note of just writing is aramid fiber material.

Further, the warning strip is made of magnesium, and the warning strip is gradually oxidized and blackened into magnesium oxide when contacting with air.

Compared with the prior art, the utility model discloses following beneficial effect has: the utility model discloses a device is through pasting this device at the injection position, write the strip and write injection time just, whether the patient forgets that there is the evidence to follow when injecting, fail in time to discover to arouse patient panic after preventing to inject the position hemorrhage, through setting up the oxidation degree of warning strip according to magnesium and referring to injection time last time for the doctor, avoid writing on the strip just because patient friction fuzzily leads to unable understanding injection time, through setting up square groove, it absorbs to be convenient for inject the position hemorrhage and see through the layer that absorbs water, the medicine layer medicine that also is convenient for permeates injection department, through setting up the isolation layer, it outwards volatilizes to reduce the medicine.

Drawings

Fig. 1 is an explosion diagram of the whole structure of the present invention.

Fig. 2 is the structural schematic diagram of the overall laminating state of the present invention.

In the figure: 1. an adhesive layer; 2. a water-absorbing layer; 3. a square groove; 4. a drug layer; 5. an isolation layer; 6. a protective layer; 7. writing a bar; 8. and (4) an alarm strip.

Detailed Description

In order to make the technical means, creation features, achievement purposes and functions of the present invention easy to understand, the present invention is further described below with reference to the following embodiments.

As shown in fig. 1-2, a prevent injection subsides of bleeding after injection of low molecular heparin, including viscose layer 1, the middle part of viscose layer 1 is provided with square groove 3, the one end of viscose layer 1 bonds and has the layer 2 that absorbs water, the one end middle part on layer 2 that absorbs water is provided with medicine layer 4, the one end on layer 2 that absorbs water bonds and has protective layer 6, the one end of medicine layer 4 bonds and has isolation layer 5, the one end of protective layer 6 is provided with just writing strip 7, just writing one side of strip 7 is provided with warning strip 8.

Wherein, viscose layer 1 is medical silica gel material, the size of the square groove 3 that viscose layer 1 middle part set up is unanimous with the size of medicine layer 4, viscose layer 1's downside surface scribbles the pressure sensitive adhesive, and viscose layer 1 is convenient for and skin in close contact with, avoids anaphylactic, is difficult to drop, is convenient for the injection position to breathe freely and medicine layer 4 medicine permeates the injection position through setting up square groove 3.

Wherein, the water absorption layer 2 is made of fiber cotton, the water absorption layer 2 adopts a multilayer combined structure, and the water absorption layer 2 is breathable and absorbs blood without influencing the drug permeation of the drug layer 4.

Wherein, isolation layer 5 is polyurethane plastic film, the size of isolation layer 5 is unanimous with the size of medicine layer 4, reduces medicine layer 4 medicine through isolation layer 5 and volatilizees.

The protective layer 6 is a fabric woven by absorbent cotton, one side of the protective layer 6 is thinner than the other side of the protective layer, and the protective layer 6 is firm in structure, good in air permeability and not easy to be allergic.

Wherein, just, write strip 7 bonds in the thinner one side of protective layer 6 through glue, just, write strip 7 is aramid fiber material, and the injection back of being convenient for marks injection time, aramid fiber material structure is durable, is difficult to corrode and falls.

The warning strip 8 is made of magnesium, the warning strip 8 is gradually oxidized and blackened into magnesium oxide when contacting with air, and the blackened magnesium is continuously oxidized and blackened with the air, so that doctors can conveniently refer to the interval time of the last injection.

What need to explain, the utility model relates to a prevent injection subsides of bleeding after low molecular heparin injection, in the use, the doctor injects the patient, after the injection is accomplished, take out this device, tear the protection film, paste viscose layer 1 towards patient injection position, the injection position is towards square groove 3 mouths, the blood that the patient position spills over adsorbs through layer 2 that absorbs water, medicine in medicine layer 4 permeates patient injection position, it is hemostatic, the doctor marks this time of injection on writing strip 7 just, tear the protection film of warning strip 8, pacify protective layer 6, along with time lapse, warning strip 8 along with air oxidation blackened, the doctor of being convenient for observes reference injection time.

The basic principles and the main features of the invention and the advantages of the invention have been shown and described above. It will be understood by those skilled in the art that the present invention is not limited to the above embodiments, and that the foregoing embodiments and descriptions are provided only to illustrate the principles of the present invention without departing from the spirit and scope of the present invention. The scope of the invention is defined by the appended claims and equivalents thereof.

Claims

1. The utility model provides a prevent hemorrhagic injection subsides after low molecule heparin injection, includes viscose layer (1), its characterized in that: the middle part on viscose layer (1) is provided with square groove (3), the one end on viscose layer (1) bonds and has water layer (2) that absorbs water, the one end middle part on layer (2) that absorbs water is provided with medicine layer (4), the one end on layer (2) that absorbs water bonds and has protective layer (6), the one end on medicine layer (4) bonds and has isolation layer (5), the one end of protective layer (6) is provided with just writing strip (7), just write one side of strip (7) and be provided with warning strip (8).

2. The injection patch for preventing bleeding after low molecular heparin injection according to claim 1, is characterized in that: the medical silicon gel material of viscose layer (1), the size of the size and the medicine layer (4) of the square groove (3) that viscose layer (1) middle part set up are unanimous, the downside surface of viscose layer (1) scribbles pressure sensitive adhesive.

3. The injection patch for preventing bleeding after low molecular heparin injection according to claim 1, is characterized in that: the water absorbing layer (2) is made of fiber cotton materials, and the water absorbing layer (2) is of a multi-layer combined structure.

4. The injection patch for preventing bleeding after low molecular heparin injection according to claim 1, is characterized in that: the isolating layer (5) is a polyurethane plastic film, and the size of the isolating layer (5) is consistent with that of the medicine layer (4).

5. The injection patch for preventing bleeding after low molecular heparin injection according to claim 1, is characterized in that: the protective layer (6) is a fabric woven by absorbent cotton materials, and one side of the protective layer (6) is thinner than the other side.

6. The injection patch for preventing bleeding after low molecular heparin injection according to claim 1, is characterized in that: the writing strip (7) is bonded to the thinner side of the protective layer (6) through glue, and the writing strip (7) is made of aramid fiber.

7. The injection patch for preventing bleeding after low molecular heparin injection according to claim 1, is characterized in that: the warning strip (8) is made of magnesium, and the warning strip (8) is gradually oxidized and blackened into magnesium oxide when contacting with air.